Analysts predict that Cerner Co. (NASDAQ:CERN) will report earnings of $0.63 per share for the current fiscal quarter, according to Zacks Investment Research. Eleven analysts have made estimates for Cerner’s earnings. The lowest EPS estimate is $0.62 and the highest is $0.65. Cerner posted earnings per share of $0.58 in the same quarter last year, which suggests a positive year-over-year growth rate of 8.6%. The business is expected to issue its next earnings results on Tuesday, February 5th.
On average, analysts expect that Cerner will report full-year earnings of $2.46 per share for the current year, with EPS estimates ranging from $2.45 to $2.48. For the next financial year, analysts forecast that the business will report earnings of $2.71 per share, with EPS estimates ranging from $2.64 to $2.80. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research firms that cover Cerner.
Cerner (NASDAQ:CERN) last released its quarterly earnings data on Thursday, October 25th. The company reported $0.57 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.58 by ($0.01). The company had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.36 billion. Cerner had a return on equity of 14.73% and a net margin of 15.72%.
A number of equities analysts have weighed in on CERN shares. Zacks Investment Research lowered Cerner from a “hold” rating to a “sell” rating in a research note on Monday, October 8th. Barclays lowered their price objective on Cerner from $70.00 to $67.00 and set an “equal weight” rating on the stock in a research note on Friday, October 26th. Cantor Fitzgerald reissued a “buy” rating and set a $80.00 price objective on shares of Cerner in a research note on Wednesday, September 12th. BidaskClub lowered Cerner from a “hold” rating to a “sell” rating in a research note on Friday, August 31st. Finally, KeyCorp boosted their price objective on Cerner from $74.00 to $76.00 and gave the stock an “overweight” rating in a research note on Monday, August 20th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and eleven have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $69.86.
In related news, President Zane M. Burke sold 381,139 shares of the stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $64.05, for a total transaction of $24,411,952.95. Following the transaction, the president now owns 59,539 shares of the company’s stock, valued at approximately $3,813,472.95. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, President Zane M. Burke sold 283,539 shares of the stock in a transaction dated Tuesday, September 11th. The stock was sold at an average price of $63.68, for a total value of $18,055,763.52. Following the transaction, the president now directly owns 59,539 shares in the company, valued at approximately $3,791,443.52. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,354,678 shares of company stock worth $82,344,416. Corporate insiders own 4.71% of the company’s stock.
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in Cerner by 1.4% during the 3rd quarter. Vanguard Group Inc. now owns 32,550,326 shares of the company’s stock worth $2,096,567,000 after acquiring an additional 462,447 shares in the last quarter. Morgan Stanley lifted its stake in Cerner by 25.4% during the 3rd quarter. Morgan Stanley now owns 3,201,690 shares of the company’s stock worth $206,221,000 after acquiring an additional 649,256 shares in the last quarter. Legal & General Group Plc lifted its stake in Cerner by 2.3% during the 3rd quarter. Legal & General Group Plc now owns 1,536,718 shares of the company’s stock worth $98,981,000 after acquiring an additional 34,838 shares in the last quarter. Standard Life Aberdeen plc lifted its stake in Cerner by 0.5% during the 3rd quarter. Standard Life Aberdeen plc now owns 753,876 shares of the company’s stock worth $48,557,000 after acquiring an additional 4,120 shares in the last quarter. Finally, Sawgrass Asset Management LLC lifted its stake in Cerner by 49.9% during the 3rd quarter. Sawgrass Asset Management LLC now owns 456,112 shares of the company’s stock worth $29,378,000 after acquiring an additional 151,933 shares in the last quarter. 77.70% of the stock is currently owned by hedge funds and other institutional investors.
NASDAQ CERN opened at $53.73 on Friday. The firm has a market cap of $18.08 billion, a price-to-earnings ratio of 24.42, a P/E/G ratio of 1.79 and a beta of 0.96. The company has a current ratio of 2.63, a quick ratio of 2.60 and a debt-to-equity ratio of 0.09. Cerner has a fifty-two week low of $50.91 and a fifty-two week high of $73.43.
Cerner Company Profile
Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Read More: Day Trading
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.